{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T05:44:34Z","timestamp":1792734274550,"version":"4.5.0"},"reference-count":36,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T00:00:00Z","timestamp":1630281600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Triptolide exerts strong anti-inflammatory and immunomodulatory effects; however, its oral administration might be associated with side effects. Transdermal administration can improve the safety of triptolide. In this study, glycerosomes were prepared as the transdermal vehicle to enhance the transdermal delivery of triptolide. With entrapment efficiency and drug loading as dependent variables, the glycerosome formulation was optimized using an orthogonal experimental design. Phospholipid-to-cholesterol and phospholipid-to-triptolide mass ratios of 30:1 and 5:1, respectively and a glycerol concentration of 20 % (\n                    <jats:italic>V\/V<\/jats:italic>\n                    ) were used in the optimization. The glycerosomes prepared with the optimized formulation showed good stability, with an average particle size of 153.10 \u00b1 2.69 nm, a zeta potential of \u201345.73 \u00b1 0.60 mV and an entrapment greater than 75 %. Glycerosomes significantly increased the transdermal delivery of triptolide compared to conventional liposomes. As efficient carriers for the transdermal delivery of drugs, glycerosomes can potentially be used as an alternative to oral triptolide administration.\n                  <\/jats:p>","DOI":"10.2478\/acph-2022-0006","type":"journal-article","created":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T17:44:30Z","timestamp":1630431870000},"page":"135-146","source":"Crossref","is-referenced-by-count":35,"title":["Optimizing glycerosome formulations\n                    <i>via<\/i>\n                    an orthogonal experimental design to enhance transdermal triptolide delivery"],"prefix":"10.2478","volume":"72","author":[{"given":"Chunyun","family":"Zhu","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Sciences , Shanghai University of Traditional, Chinese Medicine , Shanghai 201203 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongtai","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences , Shanghai University of Traditional, Chinese Medicine , Shanghai 201203 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences , Shanghai University of Traditional, Chinese Medicine , Shanghai 201203 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zehui","family":"He","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences , Shanghai University of Traditional, Chinese Medicine , Shanghai 201203 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences , Shanghai University of Traditional, Chinese Medicine , Shanghai 201203 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nianping","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences , Shanghai University of Traditional, Chinese Medicine , Shanghai 201203 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2021,8,30]]},"reference":[{"key":"2026051108211952239_j_acph-2022-0006_ref_001","unstructured":"1. Y. Fu, Q. Lin and Z. Zhang, Determination of apparent solubility-apparent oil \/water partition coefficient and dissociation constant of triptolide and triptolide-glucosamine conjugate, W. China J. Pharm. Sci. 32 (2017) 369\u2013371; https:\/\/doi.org\/10.13375\/j.cnki.wcjps.2017.04.008 (Chinese)"},{"key":"2026051108211952239_j_acph-2022-0006_ref_002","doi-asserted-by":"crossref","unstructured":"2. X. Song, Y. Zhang and E. Dai, Therapeutic targets of thunder god vine (Tripterygium wilfordii hook) in rheumatoid arthritis (Review), Mol. Med. Rep. 21 (2020) 2303\u20132310; https:\/\/doi.org\/10.3892\/mmr.2020.1105210.3892\/mmr.2020.1105232323812","DOI":"10.3892\/mmr.2020.11052"},{"key":"2026051108211952239_j_acph-2022-0006_ref_003","doi-asserted-by":"crossref","unstructured":"3. Z. Yuan, Z. Yuan, M. Hasnat, H. Zhang, P. Liang, L. Sun, Z. Jiang and L. Zhang, A new perspective of triptolide-associated hepatotoxicity: the relevance of NF-\u03baB and NF-\u03baB-mediated cellular FLICE-inhibitory protein, Acta Pharm. Sin. B. 10 (2020) 861\u2013877; https:\/\/doi.org\/10.1016\/j.apsb.2020.02.00910.1016\/j.apsb.2020.02.009728015032528833","DOI":"10.1016\/j.apsb.2020.02.009"},{"key":"2026051108211952239_j_acph-2022-0006_ref_004","doi-asserted-by":"crossref","unstructured":"4. H. Zhao, Y. Tong, D. Lu and B. Wu, Circadian clock regulates hepatotoxicity of Tripterygium wilfordii through modulation of metabolism, J. Pharm. Pharmacol. (2020); https:\/\/doi.org\/doi:10.1111\/jphp.13299.10.1111\/jphp.1329932478421","DOI":"10.1111\/jphp.13299"},{"key":"2026051108211952239_j_acph-2022-0006_ref_005","doi-asserted-by":"crossref","unstructured":"5. H. Zeng, X. Zhu, Q. Tian, Y. Yan, L. Zhang, M. Yan, R. Li, X. Li, G. Wang, J. Ma, Y. Su, X. Zhang, L. Ma, Z. Zhang and X. Wu, In vivo antitumor effects of carboxymethyl chitosan-conjugated triptolide after oral administration, Drug Deliv. 27 (2020) 848\u2013854; https:\/\/doi.org\/10.1080\/10717544.2020.177037010.1080\/10717544.2020.1770370821644332508161","DOI":"10.1080\/10717544.2020.1770370"},{"key":"2026051108211952239_j_acph-2022-0006_ref_006","doi-asserted-by":"crossref","unstructured":"6. O. A. Al Hanbali, H. M. S. Khan, M. Sarfraz, M. Arafat, S. Ijaz and A. Hameed, Transdermal patches: Design and current approaches to painless drug delivery, Acta Pharm. 69 (2019) 197\u2013215; https:\/\/doi.org\/10.2478\/acph-2019-001610.2478\/acph-2019-001631259729","DOI":"10.2478\/acph-2019-0016"},{"key":"2026051108211952239_j_acph-2022-0006_ref_007","unstructured":"7. E. Touitou, Compositions for Applying Active Substances to or Through the Skin, U.S. Pat. 5,540,934 A, 30 Jul 1996."},{"key":"2026051108211952239_j_acph-2022-0006_ref_008","doi-asserted-by":"crossref","unstructured":"8. M. L. Manca, M. Zaru, M. Manconi, F. Lai, D. Valenti, C. Sinico and A. M. Fadda, Glycerosomes: a new tool for effective dermal and transdermal drug delivery, Int. J. Pharm. 455 (2013) 66\u201374; https:\/\/doi.org\/10.1016\/j.ijpharm.2013.07.06010.1016\/j.ijpharm.2013.07.06023911913","DOI":"10.1016\/j.ijpharm.2013.07.060"},{"key":"2026051108211952239_j_acph-2022-0006_ref_009","doi-asserted-by":"crossref","unstructured":"9. M. Manconi, G. Petretto, G. D\u2019hallewin, E. Escribano, E. Milia, R. Pinna, A. Palmieri, M. Firoznezhad, J. E. Peris, I. Usach, A. M. Fadda, C. Caddeo and M. L. Manca, Thymus essential oil extraction, characterization and incorporation in phospholipid vesicles for the antioxidant\/antibacterial treatment of oral cavity diseases, Colloids Surf. B Biointerfaces. 171 (2018) 115\u2013122; https:\/\/doi.org\/10.1016\/j.colsurfb.2018.07.02110.1016\/j.colsurfb.2018.07.02130025373","DOI":"10.1016\/j.colsurfb.2018.07.021"},{"key":"2026051108211952239_j_acph-2022-0006_ref_010","doi-asserted-by":"crossref","unstructured":"10. M. Pleguezuelos-Villa, O. Diez-Sales, M. L. Manca, M. Manconi, A. R. Sauri, E. Escribano-Ferrer and A. N\u00e1cher, Mangiferin glycethosomes as a new potential adjuvant for the treatment of psoriasis, Int. J. Pharm. 573 (2020) 118844; https:\/\/doi.org\/10.1016\/j.ijpharm.2019.11884410.1016\/j.ijpharm.2019.11884431751638","DOI":"10.1016\/j.ijpharm.2019.118844"},{"key":"2026051108211952239_j_acph-2022-0006_ref_011","doi-asserted-by":"crossref","unstructured":"11. M. Manconi, M. L. Manca, F. Marongiu, C. Caddeo, I. Castangia, G. L. Petretto, G. Pintore, G. Sarais, G. D\u2019hallewin, M. Zaru, G. Bacchetta and A. M. Fadda, Chemical characterization of Citrus limon var. pompia and incorporation in phospholipid vesicles for skin delivery, Int. J. Pharm. 506 (2016) 449\u2013457; https:\/\/doi.org\/10.1016\/j.ijpharm.2016.04.01410.1016\/j.ijpharm.2016.04.01427084291","DOI":"10.1016\/j.ijpharm.2016.04.014"},{"key":"2026051108211952239_j_acph-2022-0006_ref_012","doi-asserted-by":"crossref","unstructured":"12. V. Melis, M. L. Manca, E. Bullita, E. Tamburini, I. Castangia, M. C. Cardia, D. Valenti, A. M. Fadda, J. E. Peris and M. Manconi, Inhalable polymer-glycerosomes as safe and effective carriers for rifampicin delivery to the lungs, Colloids Surf. B Biointerfaces. 143 (2016) 301\u2013308; https:\/\/doi.org\/10.1016\/j.colsurfb.2016.03.04410.1016\/j.colsurfb.2016.03.04427022870","DOI":"10.1016\/j.colsurfb.2016.03.044"},{"key":"2026051108211952239_j_acph-2022-0006_ref_013","doi-asserted-by":"crossref","unstructured":"13. H. Liu, M. Shen, D. Zhao, D. Ru, Y. Duan, C. Ding and H. Li, The effect of triptolide-loaded exosomes on the proliferation and apoptosis of human ovarian cancer SKOV3 cells, Biomed. Res. Int. 2019 (2019) 2595801; https:\/\/doi.org\/10.1155\/2019\/259580110.1155\/2019\/2595801655636731240207","DOI":"10.1155\/2019\/2595801"},{"key":"2026051108211952239_j_acph-2022-0006_ref_014","doi-asserted-by":"crossref","unstructured":"14. X. Niu, D. Zhang, Q. Bian, X. Feng, H. Li, Y. Rao, Y. Shen, F. Geng, A. Yuan, X. Ying and J. Gao, Mechanism investigation of ethosomes transdermal permeation, Int. J. Pharm. 1 (2019) 100027; https:\/\/doi.org\/10.1016\/j.ijpx.2019.10002710.1016\/j.ijpx.2019.100027673329131517292","DOI":"10.1016\/j.ijpx.2019.100027"},{"key":"2026051108211952239_j_acph-2022-0006_ref_015","doi-asserted-by":"crossref","unstructured":"15. F. J. Leyva-Jim\u00e9nez, M. L. Manca, M. Manconi, C. Caddeo, J. A. V\u00e1zquez, J. Lozano-S\u00e1nchez, E. Escribano-Ferrer, D. Arr\u00e1ez-Rom\u00e1n and A. Segura-Carretero, Incorporation of lippia citriodora microwave extract into total-green biogelatin-phospholipid vesicles to improve its antioxidant activity, Nanomaterials (Basel). 10 (2020) 765; https:\/\/doi.org\/10.3390\/nano1004076510.3390\/nano10040765722174432316238","DOI":"10.3390\/nano10040765"},{"key":"2026051108211952239_j_acph-2022-0006_ref_016","doi-asserted-by":"crossref","unstructured":"16. Y. Suzuki, T. Ogasawara, Y. Tanaka, H. Takeda, T. Sawasaki, M. Mogi, S. Liu and K. Maeyama, Functional G-protein-coupled receptor (GPCR) synthesis: The pharmacological analysis of human histamine H1 receptor (HRH1) synthesized by a wheat germ cell-free protein synthesis system combined with asolectin glycerosomes, Front. Pharmacol. 9 (2018) 38; https:\/\/doi.org\/10.3389\/fphar.2018.0003810.3389\/fphar.2018.00038580819529467651","DOI":"10.3389\/fphar.2018.00038"},{"key":"2026051108211952239_j_acph-2022-0006_ref_017","doi-asserted-by":"crossref","unstructured":"17. R. Pinna, E. Filigheddu, C. Juliano, A. Palmieri, M. Manconi, G. D\u2019hallewin, G. Petretto, M. Maioli, C. Caddeo, M. L. Manca, G. Solinas, A. Bortone, V. Campanella and E. Milia, Antimicrobial effect of Thymus capitatus and Citrus limon var. pompia as raw extracts and nanovesicles, Pharmaceutics. 11 (2019) 234; https:\/\/doi.org\/10.3390\/pharmaceutics1105023410.3390\/pharmaceutics11050234657259531091818","DOI":"10.3390\/pharmaceutics11050234"},{"key":"2026051108211952239_j_acph-2022-0006_ref_018","doi-asserted-by":"crossref","unstructured":"18. M. Manconi, M. L. Manca, C. Caddeo, G. Sarais, A. Palmieri, G. D\u2019Hallewin and A. M. Fadda, Citrus limon extract loaded in vesicular systems for the protection of oral cavity, Medicines (Basel) 5 (2018) 108; https:\/\/doi.org\/10.3390\/medicines504010810.3390\/medicines5040108631344230322189","DOI":"10.3390\/medicines5040108"},{"key":"2026051108211952239_j_acph-2022-0006_ref_019","doi-asserted-by":"crossref","unstructured":"19. M. Allaw, M. Manconi, M. Aroffu, F. Marongiu, M. Porceddu, G. Bacchetta, I. Usach, R. A. Rached, H. N. Rajha, R. G. Maroun, J. L. Pedraz, T. B. Lopez-Mendez, A. M. Fadda and M. L. Manca, Extraction, characterization and incorporation of Hypericum scruglii extract in ad hoc formulated phospholipid vesicles designed for the treatment of skin diseases connected with oxidative stress, Pharmaceutics 12 (2020) 1010; https:\/\/doi.org\/10.3390\/pharmaceutics1211101010.3390\/pharmaceutics12111010769074833113923","DOI":"10.3390\/pharmaceutics12111010"},{"key":"2026051108211952239_j_acph-2022-0006_ref_020","doi-asserted-by":"crossref","unstructured":"20. M. Manca, J. Peris, V. Melis, D. Valenti, M. Cardia, D. Lattuada, E. Ferrer, A. Faddaa and M. Manconi, Nanoincorporation of curcumin in polymer-glycerosomes and evaluation of their in vitro-in vivo suitability as pulmonary delivery systems, RSC Adv. 127 (2015) 105149\u2013105159; https:\/\/doi.org\/10.1039\/C5RA24032H10.1039\/C5RA24032H","DOI":"10.1039\/C5RA24032H"},{"key":"2026051108211952239_j_acph-2022-0006_ref_021","unstructured":"21. C. Caddeo, M. L. Manca, M. Matos, G. Gutierrez, O. D\u00edez-Sales, J. E. Peris, I. Usach, X. Fern\u00e0ndez-Busquets, A. M. Fadda and M. Manconi, Functional response of novel bioprotective poloxamer-structured vesicles on inflamed skin, Nanomedicine 13 (2017) 1127\u20131136; https:\/\/doi.org\/10.1016\/j.nano.2016.12.01710.1016\/j.nano.2016.12.01728064008"},{"key":"2026051108211952239_j_acph-2022-0006_ref_022","doi-asserted-by":"crossref","unstructured":"22. G. Poovi and N. Damodharan, Development of tamoxifen-loaded surface-modified nanostructured lipid carrier using experimental design: in vitro and ex vivo characterization, IET Nanobiotechnol. 14 (2020) 261\u2013274; https:\/\/doi.org\/10.1049\/iet-nbt.2019.027610.1049\/iet-nbt.2019.0276867662332463016","DOI":"10.1049\/iet-nbt.2019.0276"},{"key":"2026051108211952239_j_acph-2022-0006_ref_023","doi-asserted-by":"crossref","unstructured":"23. Y. T. Zhang, Y. M. Xu, S. J. Zhang, J. H. Zhao, Z. Wang, D. Q. Xu and N. P. Feng, In vivo micro-dialysis for the evaluation of transfersomes as a novel transdermal delivery vehicle for cinnamic acid, Drug Dev. Ind. Pharm. 40 (2014) 301\u2013307; https:\/\/doi.org\/10.3109\/03639045.2012.75688810.3109\/03639045.2012.756888","DOI":"10.3109\/03639045.2012.756888"},{"key":"2026051108211952239_j_acph-2022-0006_ref_024","doi-asserted-by":"crossref","unstructured":"24. H. F. Salem, R. M. Kharshoum, O. M. Sayed and L. F. Abdel Hakim, Formulation design and optimization of novel soft glycerosomes for enhanced topical delivery of celecoxib and cupferron by Box-Behnken statistical design, Drug Dev. Ind. Pharm. 44 (2018) 1871\u20131884; https:\/\/doi.org\/10.1080\/03639045.2018.150496310.1080\/03639045.2018.1504963","DOI":"10.1080\/03639045.2018.1504963"},{"key":"2026051108211952239_j_acph-2022-0006_ref_025","doi-asserted-by":"crossref","unstructured":"25. I. A. Naguib, E. A. Abdelaleem, E. S. Hassan, N. W. Ali and M. Gamal, Partial least squares and linear support vector regression chemometric models for analysis of norfloxacin and tinidazole with tinidazole impurity, Spectrochim. Acta A Mol. Biomol. Spectrosc. 239 (2020) 118513; https:\/\/doi.org\/10.1016\/j.saa.2020.11851310.1016\/j.saa.2020.118513","DOI":"10.1016\/j.saa.2020.118513"},{"key":"2026051108211952239_j_acph-2022-0006_ref_026","doi-asserted-by":"crossref","unstructured":"26. M. L. Manca, C. Cencetti, P. Matricardi, I. Castangia, M. Zaru, O. D. Sales, A. Nacher, D. Valenti, A. M. Maccioni, A. M. Fadda and M. Manconi, Glycerosomes: Use of hydrogenated soy phosphatidylcholine mixture and its effect on vesicle features and diclofenac skin penetration, Int. J. Pharm. 511 (2016) 198\u2013204; https:\/\/doi.org\/10.1016\/j.ijpharm.2016.07.00910.1016\/j.ijpharm.2016.07.009","DOI":"10.1016\/j.ijpharm.2016.07.009"},{"key":"2026051108211952239_j_acph-2022-0006_ref_027","unstructured":"27. E. Touitou, Compositions for Applying Active Substances to or Through the Skin, U.S. Pat. 5,716,638, 10 Feb 1998."},{"key":"2026051108211952239_j_acph-2022-0006_ref_028","doi-asserted-by":"crossref","unstructured":"28. M. M. Abdellatif, I. A. Khalil and M. A. F. Khalil, Sertaconazole nitrate loaded nanovesicular systems for targeting skin fungal infection: In-vitro, ex-vivo and in-vivo evaluation, Int. J. Pharm. 527 (2017) 1\u201311; https:\/\/doi.org\/10.1016\/j.ijpharm.2017.05.02910.1016\/j.ijpharm.2017.05.029","DOI":"10.1016\/j.ijpharm.2017.05.029"},{"key":"2026051108211952239_j_acph-2022-0006_ref_029","doi-asserted-by":"crossref","unstructured":"29. B. Godin and E. Touitou, Ethosomes: new prospects in transdermal delivery, Crit. Rev. Ther. Drug Carrier Syst. 20 (2003) 63\u2013102; https:\/\/doi.org\/10.1615\/critrevtherdrugcarriersyst.v20.i1.2010.1615\/CritRevTherDrugCarrierSyst.v20.i1.20","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v20.i1.20"},{"key":"2026051108211952239_j_acph-2022-0006_ref_030","doi-asserted-by":"crossref","unstructured":"30. J. Vitonyte, M. L. Manca, C. Caddeo, D. Valenti, J. E. Peris, I. Usach, A. Nacher, M. Matos, G. Guti\u00e9rrez, G. Orr\u00f9, X. Fern\u00e0ndez-Busquets, A. M. Fadda and M. Manconi, Bifunctional viscous nanovesicles co-loaded with resveratrol and gallic acid for skin protection against microbial and oxidative injuries, Eur. J. Pharm. Biopharm. 114 (2017) 278\u2013287; https:\/\/doi.org\/10.1016\/j.ejpb.2017.02.00410.1016\/j.ejpb.2017.02.004","DOI":"10.1016\/j.ejpb.2017.02.004"},{"key":"2026051108211952239_j_acph-2022-0006_ref_031","doi-asserted-by":"crossref","unstructured":"31. M. J. Naguib, S. Salah, S. A. Abdel Halim and S. M. Badr-Eldin, Investigating the potential of utilizing glycerosomes as a novel vesicular platform for enhancing intranasal delivery of lacidipine, Int. J. Pharm. 582 (2020) 119302; https:\/\/doi.org\/10.1016\/j.ijpharm.2020.11930210.1016\/j.ijpharm.2020.119302","DOI":"10.1016\/j.ijpharm.2020.119302"},{"key":"2026051108211952239_j_acph-2022-0006_ref_032","doi-asserted-by":"crossref","unstructured":"32. K. Zhang, Y. Zhang, Z. Li, N. Li and N. Feng, Essential oil-mediated glycerosomes increase transdermal paeoniflorin delivery: optimization, characterization and evaluation in vitro and in vivo, Int. J. Nanomedicine. 12 (2017) 3521\u20133532; https:\/\/doi.org\/10.2147\/IJN.S13574910.2147\/IJN.S135749","DOI":"10.2147\/IJN.S135749"},{"key":"2026051108211952239_j_acph-2022-0006_ref_033","doi-asserted-by":"crossref","unstructured":"33. P. Westh, Unilamellar DMPC vesicles in aqueous glycerol: preferential interactions and thermo-chemistry, Biophys. J. 84 (2003) 341\u2013349; https:\/\/doi.org\/10.1016\/S0006-3495(03)74854-110.1016\/S0006-3495(03)74854-1","DOI":"10.1016\/S0006-3495(03)74854-1"},{"key":"2026051108211952239_j_acph-2022-0006_ref_034","doi-asserted-by":"crossref","unstructured":"34. M. L. Manca, I. Castangia, C. Caddeo, D. Pando, E. Escribano, D. Valenti, S. Lampis, M. Zaru, A. M. Fadda and M. Manconi, Improvement of quercetin protective effect against oxidative stress skin damages by incorporation in nanovesicles, Colloids Surf. B Biointerfaces 123 (2014) 566\u2013574; https:\/\/doi.org\/10.1016\/j.colsurfb.2014.09.05910.1016\/j.colsurfb.2014.09.05925444664","DOI":"10.1016\/j.colsurfb.2014.09.059"},{"key":"2026051108211952239_j_acph-2022-0006_ref_035","doi-asserted-by":"crossref","unstructured":"35. T. Moolakkadath, M. Aqil, A. Ahad, S. S. Imam, A. Praveen, Y. Sultana and M. Mujeeb, Preparation and optimization of fisetin loaded glycerol based soft nanovesicles by Box-Behnken design, Int. J. Pharm. 578 (2020) 119125; https:\/\/doi.org\/10.1016\/j.ijpharm.2020.11912510.1016\/j.ijpharm.2020.11912532036010","DOI":"10.1016\/j.ijpharm.2020.119125"},{"key":"2026051108211952239_j_acph-2022-0006_ref_036","doi-asserted-by":"crossref","unstructured":"36. M. L. Manca, M. Manconi, M. Zaru, D. Valenti, J. E. Peris, P. Matricardi, A. M. Maccioni and A. M. Fadda, Glycerosomes: Investigation of role of 1,2-dimyristoyl-sn-glycero-3-phosphatidycholine (DMPC) on the assembling and skin delivery performances, Int. J. Pharm. 532 (2017) 401\u2013407; https:\/\/doi.org\/10.1016\/j.ijpharm.2017.09.02610.1016\/j.ijpharm.2017.09.02628917990","DOI":"10.1016\/j.ijpharm.2017.09.026"}],"container-title":["Acta Pharmaceutica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/reference-global.com\/pdf\/10.2478\/acph-2022-0006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T08:50:14Z","timestamp":1778489414000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.2478\/acph-2022-0006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,30]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,8,30]]},"published-print":{"date-parts":[[2022,3,1]]}},"alternative-id":["10.2478\/acph-2022-0006"],"URL":"https:\/\/doi.org\/10.2478\/acph-2022-0006","relation":{},"ISSN":["1846-9558"],"issn-type":[{"value":"1846-9558","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,30]]}}}